IRCCS Centro Cardiologico Fondazione Monzino

Milan, MI 20138

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Hyperlipidemia

Studies at this site

• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed